Repository logo
 
Publication

Cellular characterization of normal and mutant cystatin B

dc.contributor.authorDuarte, Ana Joana
dc.contributor.authorRibeiro, Diogo
dc.contributor.authorChaves, João
dc.contributor.authorAmaral, Olga
dc.date.accessioned2015-01-29T12:22:11Z
dc.date.available2015-01-29T12:22:11Z
dc.date.issued2014-12-19
dc.descriptionA.J.Duarte received a grant awarded by Genzyme/SPDMpor
dc.description.abstractUnverricht- Lundborg disease (ULD or EPM1, MIM 254800), is a myoclonic epilepsy, caused by mutations in the cystatin B gene (CSTB gene) which lead to impaired function of cystatin B compromising its function. The normal protein is an endogenous inhibitor of cysteine proteinases and has several cellular localizations, it is found in the nucleus, cytosol and lysosome. Identification of a rare molecular mechanism causal of Unverricht Lundborg disease in a unique Portuguese patient triggered research in this field. Skin fibroblasts were obtained with informed consent from a homozygous patient with a rare genotype and from a normal control (anonymized). Fibroblast cell cultures were expanded using standard methods. Western Blotting (WB) and immunofluorescence (IF) experiments were carried out following previous described methods (Pinto et al, 2012). For cell fractionation analysis, cells were collected by scraping and suspending in ice-cold phosphate buffer saline (PBS) and cell fractions where obtained using the methods described elsewhere (Suzuki et al, 2010). Immunofluorescence experimental results revealed consistency with the western blot analysis. Although with a decrease of about 4 fold, in relation to normal, cystatin B is clearly present in the cells’ total fraction and in the nuclear fraction. However, in the cytoplasm the decrease seems to be higher which could suggest a subsequent lower protective anti-protease function compromising cellular and lysosomal integrity. Discussion and future perspectives In patient’s fibroblasts the protein quantity is diminished. Although the nuclear location seems to be preserved in the patient´s cells, the cytoplasmic/lysosomal fraction is clearly decreased.por
dc.description.sponsorshipSociedade Portuguesa de Doenças Metabólicas (SPDM) and Genzyme under project DGH (2013)por
dc.identifier.urihttp://hdl.handle.net/10400.18/2704
dc.language.isoengpor
dc.peerreviewedyespor
dc.relationproject DGH (2013)por
dc.subjectGenética Humanapor
dc.subjectDoenças Raraspor
dc.subjectEpilepsiapor
dc.subjectUnverritch Lundborgpor
dc.subjectCistatina Bpor
dc.subjectCSTBpor
dc.subjectWestern Analysispor
dc.subjectImmunofluorescencepor
dc.subjectDoenças Genéticaspor
dc.titleCellular characterization of normal and mutant cystatin Bpor
dc.typeconference object
dspace.entity.typePublication
oaire.citation.conferencePlaceCoimbra, Portugalpor
oaire.citation.titleXVIII congress of the Portuguese biochemical society, 17-20 December 2014por
rcaap.rightsrestrictedAccesspor
rcaap.typeconferenceObjectpor

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
SPB-2014-dez.jpg
Size:
134.52 KB
Format:
Joint Photographic Experts Group/JPEG File Interchange Format (JFIF)
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: